CLINICAL RESEARCH: VIEWPOINT
C-Reactive Protein Increase in Unstable Coronary Disease
Cause or Effect?
Stefano De Servi, MD, FESC*,*,
Matteo Mariani, MD*,
Giuseppe Mariani, MD* and
Antonino Mazzone, MD
* Cardiovascular Disease
Internal Medicine, Ospedale Civile di Legnano, Legnano (Milan), Italy
Manuscript received April 13, 2005;
revised manuscript received May 27, 2005,
accepted May 31, 2005.
* Reprint requests and correspondence: Dr. Stefano De Servi, Unit of Cardiology, Ospedale Civile di Legnano, Via Candiani, 2, Legnano (Milan), Italy
(Email: cardiologialegnano{at}ao-legnano.it).
A crucial point in understanding the clinical and pathophysiologic meaning of C-reactive protein (CRP) elevation in acute coronary syndromes (ACS) is whether CRP release is predominantly a response to even small amounts of myocardial necrosis, for which troponin is a sensitive and specific marker, or is an independent indicator of the inflammatory process occurring in that clinical condition. Whereas troponin is a good predictor of both mortality and myocardial infarction (MI), although the highest values are associated with a decreased probability of MI, CRP predicts mortality but has no relation with the early or late occurrence of MI. The large variability of CRP values in ACS may depend on the different response of this inflammation marker to various stimuli, some patients being particularly hyperresponsive, especially those with elevated CRP values at baseline. We hypothesize that myonecrosis, as detected by troponin increases, would represent the strongest stimulus for CRP increase in ACS, causing in some patients, especially those with already-elevated CRP values at baseline, a disproportionate increase of this marker. Accordingly, the highest CRP values during ACS are likely to be observed in patients with already-elevated CRP values at baseline (which would increase the probability of having death and MI in the follow-up) and the highest troponin values (which would increase the probability of death in the follow-up, but not of subsequent MI). This hypothesis would explain why high CRP levels in unstable coronary disease are good predictors of death, but not of MI.
|
Abbreviations and Acronyms
| | ACS = acute coronary syndrome | | CI = confidence interval | | CRP = C-reactive protein | | IL = interleukin | | MI = myocardial infarction | | OR = odds ratio | | TNF = tumor necrosis factor |
|
This article has been cited by other articles:
|
|
|
|
 
T. Ibrahim, M. R. Makowski, A. Jankauskas, D. Maintz, M. Karch, S. Schachoff, W. J. Manning, A. Schomig, M. Schwaiger, and R. M. Botnar
Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
580 - 588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Amano, T. Matsubara, T. Uetani, M. Nanki, N. Marui, M. Kato, K. Arai, K. Yokoi, H. Ando, H. Ishii, et al.
Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary Lesions: Integrated Backscatter Intravascular Ultrasound Study
J. Am. Coll. Cardiol.,
March 20, 2007;
49(11):
1149 - 1156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Marsik, R. Sunder-Plassmann, B. Jilma, F. M. Kovar, C. Mannhalter, O. Wagner, H. Rumpold, and G. Endler
The C-Reactive Protein +1444C/T Alteration Modulates the Inflammation and Coagulation Response in Human Endotoxemia
Clin. Chem.,
October 1, 2006;
52(10):
1952 - 1957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. B. Keller and L. Lemberg
Secondary prevention of coronary artery disease in elderly persons: a treatise on a report by the american heart association.
Am. J. Crit. Care.,
September 1, 2006;
15(5):
514 - 518.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. D. Sin and S. F. P. Man
Is Systemic Inflammation Responsible for Pulmonary Hypertension in COPD?
Chest,
August 1, 2006;
130(2):
310 - 312.
[Full Text]
[PDF]
|
|
|
|
